Cowen And Company, LLC Blueprint Medicines Corp Call Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 03, 2020
SELL
$66.45 - $92.7 $1.99 Million - $2.78 Million
-30,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$57.09 - $79.27 $1.58 Million - $2.2 Million
27,700 Added 1204.35%
30,000 $276,000
Q1 2020

May 11, 2020
BUY
$48.11 - $82.22 $110,653 - $189,106
2,300 New
2,300 $9,000
Q4 2019

Feb 11, 2020
SELL
$66.73 - $82.59 $3.06 Million - $3.79 Million
-45,900 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$72.9 - $101.41 $3.35 Million - $4.65 Million
45,900 New
45,900 $13,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email